Thompson Davis & Co’s West Pharmaceutical WST Stock Holding History

Thompson Davis & Co’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41	Closed	-$3K	–	1248
2016 Q4	$3K	Buy	+41	New	+$3.22K	0.01%	983

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Thompson Davis & Co's WST Position: Q1 2017 in Review

Thompson Davis & Co sold out of West Pharmaceutical (WST) in Q1 2017, closing a stake of 41 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in WST in Q4 2016 and held it in 1 quarter. The position peaked at $3K in Q4 2016. 294 funds tracked by Wall St. Rank hold WST as of Q1 2017.

Thompson Davis & Co reported no remaining West Pharmaceutical position as of Q1 2017 after selling out during the quarter.
Thompson Davis & Co sold 41 West Pharmaceutical shares in Q1 2017, an estimated $3K.
Thompson Davis & Co first reported a position in West Pharmaceutical in Q4 2016 and held it in 1 quarter.
Thompson Davis & Co's West Pharmaceutical position peaked at $3K in Q4 2016.
294 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on Thompson Davis & Co's 13F filing for Q1 2017, filed 8 May 2017.